Pieter Peeters

Chief Technology & Operations Officer and Co-founder

With over 25 years of experience in the pharmaceutical industry, he brings deep expertise at the intersection of data science, bioengineering, and technology-driven drug discovery. Prior to Onco3R, Pieter served as Head of Discovery Sciences at Galapagos, where he led global teams supporting small molecule and cell therapy discovery across the R&D portfolio. He was instrumental in building and deploying AI-based platforms that enhanced early development capabilities and accelerated decision-making. Prior to Galapagos, Pieter spent over two decades at Janssen Pharmaceutica (J&J Innovative Medicine), where he held leadership roles within Janssen Research & Development. Starting as a bench scientist, he advanced into senior leadership, where he led global initiatives in technology innovation, translational science, and data-driven pipeline development. Pieter earned his PhD in Applied Biological Sciences at the Center for Human Genetics at KU Leuven, and holds a degree in bioengineering from KU Leuven with a specialization in cell and gene technology and interphase chemistry. He is known for his multidisciplinary approach, operational and scientific leadership, and commitment to enabling innovation through smart technology platforms.

Pieter Peeters - CTO and COO of Onco3R Therapeutics